NeurologyLive: Mapping Out Our 2025 Conference Journey

In 2025, NeurologyLive^® is proud to offer comprehensive coverage of some of the most influential conferences held in neurology, providing a snapshot of insights into groundbreaking research, innovative treatments, and evolving clinical practices.

Across these platform events, experts in neurology and related specialties will share the latest advancements in Alzheimer disease (AD), multiple sclerosis (MS), epilepsy, neuromuscular diseases, headache medicine, and more. From exploring the cutting-edge applications of artificial intelligence (AI) and gene therapy to addressing the unique challenges of patient-centered care, our team aims to bring you highlights from the latest data and insights from experts that shape the future of neurological care.

Here are some of the conferences for 2025 that we will be covering to help you stay informed on latest trends and transformative discoveries uncovered in the field:

Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

The 2025 ACTRIMS Forum, themed “Making Connections,” will be held February 27 - March 1 in West Palm Beach, Florida, at the Palm Beach County Convention Center and the Hilton West Palm Beach. This conference will explore cutting-edge advancements in the understanding and treatment of MS, focusing on innovative therapeutic strategies, emerging research concepts, and the integration of new technologies in clinical practice.

Topics presented at the Forum will address how to enhance patient outcomes, improve disease management, and optimize diagnostic and treatment protocols for MS. With a strong emphasis on neuroimmune interactions, disease progression, and novel clinical approaches, the event will showcase interdisciplinary efforts to advance MS care.

Key crossover topics include:

• Bruton tyrosine kinase (BTK) inhibition as a treatment strategy, targeting neuroinflammation in MS.
• Emerging concepts in MS, focusing on pathogenic mechanisms and new measures of disease activity.
• AI and machine learning in both MS research and clinical practice.
• The role of remyelination in MS repair and the challenges in clinical trials for these therapies.
• Comparative studies between MS and other neurological diseases, highlighting shared pathophysiological features.

Muscular Dystrophy Association (MDA) Clinical and Scientific Conference

The 2025 MDA Clinical and Scientific Conference will be held March 16-19, at the Hilton Anatole in Dallas, Texas. This conference will delve into the latest advancements in the diagnosis, management, and treatment of neuromuscular diseases, emphasizing innovative therapeutic strategies, gene therapy, and the integration of multidisciplinary care models. The event will highlight emerging research, particularly around muscle regeneration, genetic technologies, and new treatment pathways for various neuromuscular conditions. There will also be a focus on improving patient outcomes through a combination of clinical care, nutrition, physical therapy, and cutting-edge scientific discovery.

Key crossover topics include:

• Gene therapy advancements and applications in neuromuscular disease treatment.
• Muscle regeneration and its potential in treating diseased muscles.
• Multidisciplinary care models, promoting collaborative, patient-centered approaches.
• Leveraging genetics for new therapeutic targets, including amyotrophic lateral sclerosis and muscular dystrophies.
• Innovative approaches to patient care, incorporating physical therapy, nutrition, and community partnerships.

American Academy of Neurology (AAN) Annual Meeting

The 2025 AAN Annual Meeting will be held April 5-9 at the San Diego Convention Center in San Diego, California. This conference will highlight key advancements and evolving practices in neurology, focusing on a wide range of topics, from innovative therapeutics and diagnostic criteria to addressing disparities in care and integrating technology into clinical practice. With an emphasis on improving patient outcomes across diverse populations, the sessions will explore cutting-edge treatments, public health initiatives, and strategies to enhance neurologic care and education.

Key crossover topics include:

• Disease-modifying and behavioral therapeutics, with updates on dementia, migraine, and hypersomnia management.
• Revised diagnostic criteria, including the 2024 McDonald Criteria for MS and approaches to muscle disease and stroke care.
• Technological integration, leveraging AI and digital tools to advance clinical practice and neurology education.
• Public health and advocacy, focusing on disparities in care, neurologic outcomes across the lifespan, and supporting special populations.
• Comprehensive approaches to epilepsy, addressing surgical options and care across age spans and life stages.

Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting

The 2025 CMSC Annual Meeting will be held May 28-31 at Phoenix Convention Center, in Phoenix, Arizona. This conference will explore the evolving landscape of MS care, focusing on advancements in diagnostics, treatment strategies, and interdisciplinary approaches to patient wellness.

From updates on diagnostic criteria to innovative rehabilitation and therapeutic models, the event emphasizes a holistic approach to improving outcomes for individuals living with MS and related disorders. Sessions will also address the professional development of MS care providers, highlighting strategies for combating burnout and fostering career growth.

Key crossover topics include:

• Revisions to the McDonald diagnostic criteria and their clinical implications.
• Interdisciplinary care models, emphasizing nutrition, rehabilitation, and comprehensive wellness approaches.
• Innovative therapeutic strategies, including remyelination and advanced disease modifying therapy management.
• Myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder, with a focus on diagnostic and treatment updates.
• Addressing challenges in MS care, such as fatigue, sexual dysfunction, and provider burnout.

SLEEP

The 2025 SLEEP annual convening of the Associated Professional Sleep Societies (APSS)—a joint venture of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society (SRS)— will be held June 7-11 at the Seattle Convention Center in Seattle, Washington. This conference will delve into the evolving field of sleep medicine, focusing on cutting-edge treatments, diagnostic innovations, and the integration of emerging technologies.

Sessions will address the complexities of sleep disorders, exploring strategies to optimize patient care and improve outcomes across diverse populations. From advancing equity in sleep health to examining the interplay between sleep and other medical conditions, the event emphasizes a multidisciplinary approach to tackling challenges in sleep medicine.

Key crossover topics include:

• Emerging technologies and treatments in sleep medicine, including hypoglossal and phrenic nerve stimulation.
• Sleep apnea management, from glucagon-like peptide-1 drugs to debates on the relevance of continuous positive airway pressure therapy.
• Interdisciplinary approaches, incorporating obesity treatment, pharmacological innovations, and mental health considerations.
• Sleep health equity and strategies to extend care to underserved populations.
• Clinical and practical challenges, such as narcolepsy testing, pediatric sleep controversies, and transitioning hospitalized sleep patients.

Advanced Therapeutics in Movement and Related Disorders (ATMRD) Congress

The 2025 ATMRD Congress hosted by the Parkinson & Movement Disorder (PMD) Alliance, in partnership with MedStar Georgetown University Hospital, will be held June 27-30, at the Gaylord National Resort & Convention Center in National Harbor, Washington, DC. This conference will focus on the latest advancements and comprehensive approaches to diagnosing, managing, and treating movement disorders and related conditions.

Emphasizing both motor and nonmotor aspects of care, the sessions will provide insights into innovative therapies, diagnostic tools, and multidisciplinary strategies to enhance patient outcomes. Topics will range from advanced therapeutics for dementia to emerging treatments for Parkinson disease and Huntington disease, offering a broad spectrum of learning opportunities for clinicians.

Key crossover topics include:

• Advanced therapeutic strategies, including disease-modifying treatments for dementia and novel approaches to Parkinson psychosis and dyskinesia.
• Innovations in surgical and on-demand therapies, such as deep brain stimulation, pumps, and new solutions for acute OFF episodes.
• Comprehensive management of Huntington disease, focusing on motor symptoms, genetics, and counseling.
• Utilizing advanced diagnostics and virtual reality training to refine clinical care and enhance provider skills.
• Addressing nonmotor challenges, including hallucinations, delusions, and patient communication barriers.

American Headache Society (AHS) Annual Scientific Meeting

The 2025 AHS Annual Scientific Meeting will be held June 19-22 at the Minneapolis Convention Center in Minneapolis, Minnesota. This program delves into the evolving landscape of headache medicine, focusing on innovative research, environmental influences, and advanced therapeutic strategies. Participants will explore the intersection of technology and clinical practice while gaining insights into the mechanisms of migraine therapies. The sessions aim to advance understanding and improve patient care through interdisciplinary approaches.

Key crossover topics include:

• Current trends and future directions in headache research and treatment.
• Impact of environmental and toxic conditions on headache disorders.
• Applications of AI in headache medicine, enhancing diagnostics and management.
• Central versus peripheral mechanisms of migraine therapies and their implications for treatment.

European Committee for Treatment and Research in Multiple Sclerosis Congress (ECTRIMS)

The 2025 ECTRIMS Congress will be held September 24–26, at the Barcelona International Convention Center in Barcelona, Spain. This program provides a comprehensive exploration of the latest developments and challenges in diagnosing, managing, and treating MS and related demyelinating diseases. It highlights innovations in personalized care, neuroprotection, and the integration of emerging technologies. By addressing the spectrum of disease stages and diverse patient populations, the sessions aim to advance understanding and improve global MS care.

Key crossover topics include:

• Advancements in diagnostic criteria and challenges in early and progressive MS diagnosis.
• Emerging biomarkers and imaging for detecting disease activity and treatment response.
• Role of environmental and microbiota factors in MS and related disorders.
• AI and technology integration for improving MS care and research.
• Global and diverse perspectives on MS diagnosis, equity, and treatment approaches.

Clinical Trials on Alzheimer's Disease Conference (CTAD)

The 2025 CTAD conference will be held December 1-4, in San Diego, California. This conference focuses on the forefront of AD research and treatment, offering a deep dive into innovative therapeutic strategies, biomarkers, clinical trial design, and the integration of patient-centered care. Presentations will showcase cutting-edge advancements in drug development, precision diagnostics, and the use of emerging technologies to enhance both clinical practice and research. Emphasis will also be placed on addressing disparities in clinical trial recruitment and improving outcomes across diverse populations.

Key crossover topics include:

• Advances in biomarker development, including plasma P-tau217 assays, amyloid positron emission tomography imaging, and fluid biomarkers for clinical and research applications.
• Emerging therapeutics, such as lecanemab, donanemab, and novel approaches using THC, cannabidiol, and gene therapy for managing AD and related disorders.
• Personalized medicine, highlighting AI-driven insights, APOE-targeted therapies, and combination treatments for tailored patient care.
• Clinical trial innovations, focusing on recruitment strategies, diversity inclusion, and optimizing trial design and outcomes.
• Evolving diagnostic criteria, with updates from the International Working Group (IWG) and implications for early detection and risk reduction.

American Epilepsy Society (AES) Annual Meeting

The 2025 AES Annual Meeting will be held December 5-9, in Atlanta, Georgia. This conference will spotlight the latest innovations and multidisciplinary approaches in epilepsy care, emphasizing advancements in neuromodulation, neuroimaging, and personalized therapeutic strategies. With sessions covering pediatric, adult, and global health perspectives, the program seeks to bridge clinical practices, translational research, and emerging technologies to optimize outcomes for individuals living with epilepsy.

Key crossover topics include:

• Advancements in neuromodulation and its role in epilepsy management.
• Personalized approaches using neuroimaging to improve surgical outcomes and minimize deficits.
• Translational research accelerating future therapies for epilepsy.
• Integrating AI and technology into epilepsy care, from neuropsychology to treatment planning.
• Multidisciplinary strategies addressing transitions, pregnancy outcomes, and resource-limited settings.

Click here to view our conference coverage.